The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support companies — particularly start-ups and small and medium-sized enterprises (SME) — in bringing innovative products to the European Union (EU) market and increase their competitiveness. According to the EC, the Hub will also help companies identify available support at the EU level and how to access this support to help them expand and grow. The EC states that the Biotech and Biomanufacturing Hub explains:
- The sources of EU funding available to biotech and biomanufacturing companies;
- The research infrastructures that can support biotech or biomanufacturing research and development (R&D);
- The resources available to help biotech or biomanufacturing businesses to scale up, including networks, pilot and testing facilities, and market insights;
- The intellectual property protection to which innovative companies are entitled;
- The processes for authorizing new biotech products, such as human and veterinary medicines or feed and food ingredients, and the support offered to applicants throughout these processes; and
- The rules and requirements that companies must comply with when developing and marketing biotech products in the EU.
According to the EC, the continuous development of the Hub will be supported through a dedicated taskforce of SME advisors under the Enterprise Europe Network. The EC notes that biotechnology “is one of the fastest growing innovative industries in the EU, which has the potential to revolutionise health, agriculture, food and feed and industry in Europe over the coming years. A thriving biotechnology and biomanufacturing sector will be key to building a more competitive, innovative and resilient EU, that succeeds in its green and digital transitions.”
[View source.]
